GLP-1 Peptide Market to Reach $100B by 2030 — What It Means for Manufacturers

The global GLP-1 receptor agonist market is projected to exceed $100 billion by 2030, driven by obesity and type 2 diabetes treatment demand. As a leading GLP-1 peptide manufacturer, keruihk is positioned to support the growing need for high-purity GLP-1 APIs and analogs.

← Back to News
Newsletter

Stay Ahead in
Peptide Science

Join 5,000+ pharmaceutical and biotech professionals who receive our monthly newsletter — covering product launches, regulatory updates, and industry insights.

  • New product launches & catalog updates
  • Regulatory news & compliance updates
  • Industry trends & market insights
  • Company milestones & partnerships

Subscribe to Our Newsletter

Monthly digest, no spam. Unsubscribe anytime.

By subscribing, you agree to our Privacy Policy. No spam, ever.